Immunotherapy
Focusing on the application of gene editing of a novel target in immunotherapy, we aim to maintain the lead position in clinical applications and strive to become a global competitor in this field.



Related papers
Liao Xuebin: A New Gene Editing Target for Immune Cells Cancer Cell(IF27)
Link to Yufan website:www.yufanbio.com

Address: 106 Fengze East Road, Nansha District, Guangzhou
Email: ming-med@ming-med.com
Copyright © 2020 ming-med.com 保留所有权利 粤ICP备20029450号-1